Leonard Schleifer
Vorstandsvorsitzender bei REGENERON PHARMACEUTICALS, INC.
Vermögen: 2 157 Mio $ am 30.04.2024
Aktive Positionen von Leonard Schleifer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Vorsitzender | 09.06.2023 | - |
| Vorstandsvorsitzender | 08.01.1988 | - | |
| Gründer | 08.01.1988 | - | |
| Präsident | 08.01.1988 | - | |
| Direktor/Vorstandsmitglied | 01.01.1994 | 09.06.2023 | |
Regeneron Ireland DAC
 Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Vorstandsvorsitzender | 01.01.2013 | - |
| Gründer | 01.01.2013 | - | |
| Präsident | 01.01.2013 | - |
Karriereverlauf von Leonard Schleifer
Ehemalige bekannte Positionen von Leonard Schleifer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Weill Cornell Medical College | Corporate Officer/Principal | - | - |
Ausbildung von Leonard Schleifer
| University of Virginia | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Irland | 2 |
Operativ
| Chief Executive Officer | 2 |
| Founder | 2 |
| President | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Health Technology |
- Börse
- Insiders
- Leonard Schleifer
- Erfahrung
